Answers are grounded in this paper and cite their sources.
Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed. She presented to the emergency department with abnormal bleeding and spontaneous hemoptysis about ten days after a removal surgery of her epiglottis tumor. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.
No takes yet. Share an insight, caveat, or question.
Hajigholami et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: